Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eleven-Nineteen-Leukemia Protein IN-2 (compound 23), an ENL inhibitor, exhibits an IC50 of 10.7 nM and is utilized for leukemia research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | Eleven-Nineteen-Leukemia Protein IN-2 (compound 23), an ENL inhibitor, exhibits an IC50 of 10.7 nM and is utilized for leukemia research [1]. |
In vitro | Eleven-Nineteen-Leukemia Protein IN-2 (0-1000 nM) demonstrates inhibitory activity against ENL with an IC50 value of 10.7 nM [1]. At concentrations ranging from 0-1000 µM and over a period of 72 hours, it suppresses the viability of MOLM-13 cells with an IC50 value of 37.9 µM [1]. |
Molecular Weight | 389.45 |
Formula | C22H23N5O2 |
CAS No. | 2894121-78-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eleven-Nineteen-Leukemia Protein IN-2 2894121-78-7 Chromatin/Epigenetic Epigenetic Reader Domain inhibitor inhibit